The economic burden of TB diagnosis and treatment in South Africa

Social Science and Medicine

Volumn 130, Issue , 2015, Pages 42-50

  Foster, Nicola ^a   Vassall, Anna ^b   Cleary, Susan ^a   Cunnama, Lucy ^a   Churchyard, Gavin ^b,c   Sinanovic, Edina ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c AURUM INSTITUTE   (South Africa)

Author keywords

Catastrophic costs; Costing; Diagnosis; Economic burden; Patient costs; South Africa; Treatment; Tuberculosis

Indexed keywords

COPING STRATEGY; COST ANALYSIS; DISEASE CONTROL; DISEASE TREATMENT; ECONOMIC IMPACT; HEALTH POLICY; RESPIRATORY DISEASE; TUBERCULOSIS;

ADULT; ARTICLE; COHORT ANALYSIS; COPING BEHAVIOR; COST CONTROL; COST OF ILLNESS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; INCOME; INTERVIEW; MAJOR CLINICAL STUDY; MALE; POVERTY; SOUTH AFRICA; SYMPTOMATOLOGY; TUBERCULOSIS; ADAPTIVE BEHAVIOR; ECONOMICS; HIV INFECTIONS; LUNG TUBERCULOSIS; PATIENT ATTITUDE; PROSPECTIVE STUDY; PUBLIC HEALTH; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

SOUTH AFRICA;

ADAPTATION, PSYCHOLOGICAL; ADULT; COST OF ILLNESS; FEMALE; HEALTH EXPENDITURES; HIV INFECTIONS; HUMANS; INCOME; MALE; NATIONAL HEALTH PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; SOUTH AFRICA; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84922464226     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2015.01.046     Document Type: Article

References (41)

1. Ataguba J.E.-O. Reassessing catastrophic health-care payments with a Nigerian case study. Health Econ. Policy. Law 2011, 1-18. 10.1017/S1744133110000356.
2. Barter D.M., Agboola S.O., Murray M.B., Bärnighausen T. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa-a systematic review. BMC Public Health 2012, 12:980. 10.1186/1471-2458-12-980.
3. Booysen F., van der Berg S., Burger R., von Maltitz M., du Rand G. Using an asset Index to assess trends in poverty in seven sub-Saharan african countries. World Dev. 2008, 36:1113-1130. 10.1016/j.worlddev.2007.10.008.
4. Cleary S., Birch S., Chimbindi N., Silal S., McIntyre D. Investigating the affordability of key health services in South Africa. Soc. Sci. Med. 2013, 80:37-46. 10.1016/j.socscimed.2012.11.035.
5. Creswell J., Sahu S., Sachdeva S.K., Ditiu L., Barreira D., Mariandyshev A., Mingting C., Pillay Y. Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda. Bull. World Health Organ 2014, 92:459-460. http://dx.doi.org/10.2471/BLT.13.133116.
6. Daftary A., Padayatchi N. Social constraints to TB/HIV healthcare: accounts from coinfected patients in South Africa. AIDS Care 2012, 24:1480-1486. 10.1080/09540121.2012.672719.
7. Drummond M.F., Schulpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L. Basic types of economic evaluation. Methods for the Economic Evaluation of Health Care Programmes 2007, 24. Oxford University Press, New York.
8. Dye C., Lönnroth K., Jaramillo E., Williams B., Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull. World Health Organ 2009, 87:683-691. 10.2471/BLT.08.058453.
9. Floyd K., Wilkinson D., Gilks C. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 1997, 315:1407-1411.
10. Glick H., Doshi J., Sonnad S., Polsky D. Analysing cost. Economic Evaluation in Clinical Trials 2010, 89-113. New York.
11. Goudge J., Gilson L., Russell S., Gumede T., Mills A. Affordability, availability and acceptability barriers to health care for the chronically ill: longitudinal case studies from South Africa. BMC Health Serv. Res. 2009, 9:75-93.
12. Goudge J., Russell S., Gilson L., Gumede T., Tollman S., Mills A. Illness-related impoverishment in rural South Africa: why does social protection work for some households but not others? 2009, 251:231-251. 10.1002/jid.
13. Harris B., Goudge J., Ataguba J.E., McIntyre D., Nxumalo N., Jikwana S., Chersich M. Inequities in access to health care in South Africa. J.Public Health Policy 2011, 32(Suppl.1):S102-S123. 10.1057/jphp.2011.35.
14. Howe L.D., Hargreaves J.R., Huttly S.R.a Issues in the construction of wealth indices for the measurement of socio-economic position in low-income countries. Emerg. Themes Epidemiol. 2008, 5:3. 10.1186/1742-7622-5-3.
15. Johannesson M. The willingness to pay for health changes, the human-capital approach and the external costs. Health Policy 1996, 36:231-244. (New. York).
16. Kawabata K., Xu K., Carrin G. Preventing impoverishment through protection against catastrophic health expenditure. Bull. World Health Organ 2002, 80:612.
17. Koopmanschap M.A., Rutten F.F.H., Ineveld B.M.Van, Roijen L.Van The friction cost method for measuring indirect costs of disease. J. Health Econ. 1995, 6:171-189.
18. Lauritsen J., Bruus M. EpiData (Version 3): A Comprehensive Tool for Validated Entry and Documentation of Data 2004.
19. Lönnroth K., Castro K.G., Chakaya J.M., Chauhan L.S., Floyd K., Glaziou P., Raviglione M.C. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010, 375:1814-1829. 10.1016/S0140-6736(10)60483-7.
20. Mauch V., Woods N., Kirubi B., Kipruto H., Sitienei J., Klinkenberg E. Assessing access barriers to tuberculosis care with the tool to estimate Patients' Costs: pilot results from two districts in Kenya. BMC Public Health 2011, 11:43. 10.1186/1471-2458-11-43.
21. McIntyre D.I., Thiede M., Birch S. Access as a policy-relevant concept in low- and middle-income countries. Heal. Econ. Policy Law 2009, 4:179-193. 10.1017/S1744133109004836.
22. Oxlade O., Murray M. Tuberculosis and poverty: why are the poor at greater risk in India?. PLoS One 2012, 7:e47533. 10.1371/journal.pone.0047533.
23. Peters K. Beating About the Bush - What's Wrong with the Social Grants System in South Africa 2014, [WWW Document]. URL, (accessed 09.18.14.). http://www.blacksash.org.za/index.php/media-and-publications/in-our-opinion/929-beating-about-the-bush-whats-wrong-with-the-social-grants-system-in-south-africa.
24. Ranson M.K. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull. World Health Organ 2002, 80:613-621.
25. Republic of South Africa Department of Health National Tuberculosis Management Guidelines 2009, (Pretoria, South Africa).
26. Russell S. Ability to pay for health care: concepts and evidence. Health Policy Plan. 1996, 11:219-237.
27. Russell S. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. Am. J. Trop. Med. Hyg. 2004, 71:147-155.
28. Sinanovic E., Floyd K., Dudley L., Azevedo V., Grant R., Maher D. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int. J. Lung Dis. 2003, 7:s56-S62.
29. Spence D.P.S., Hotchkiss J., Williams C.S.D., Davies P.D.O. Tuberculosis and poverty. Br. Med. J. 1993, 307:759-761.
30. STATA Corporation STATA 13.0. Statistics South Africa, 2012. Census 2011: Statistical Release P0301.4 2013, (Pretoria).
31. Tanimura T., Jaramillo E., Weil D., Raviglione M., Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur. Respir. J. 2014, 1-13. 10.1183/09031936.00193413.
32. Tarricone R. Cost-of-illness analysis. What room in health economics?. Health Policy 2006, 77:51-63. 10.1016/j.healthpol.2005.07.016.
33. Traissac P., Martin-Prevel Y. Alternatives to principal components analtsis to derive asset-based indices to measure socio-economic position in low- and middle-income countries: the case for multiple correspondence analysis. Int. J. Epidemiol. 2012, 41:1206-1207. 10.1093/ije/dys087.
34. Ukwaja K.N., Modebe O., Igwenyi C., Alobu I. The economic burden of tuberculosis care for patients and households in Africa: a systematic review. Int. J. Tuberc. Lung Dis. 2012, 16:733-739. 10.5588/ijtld.11.0193.
35. Vassall A., Seme A., Compernolle P., Meheus F. Patient costs of accessing collaborative tuberculosis and human immunodefi ciency virus interventions in Ethiopia. World Health 2010, 14:604-610.
36. Whitehead M., Dahlgren G., Evans T. Equity and health sector reforms: can low-income countries escape the medical poverty trap?. Lancet 2001, 358:833-836. 10.1016/S0140-6736(01)05975-X.
37. Wingfield T., Boccia D., Tovar M., Gavino A., Zevallos K., Montoya R., Lönnroth K., Evans C.a Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, peru. PLoS Med. 2014, 11:e1001675. 10.1371/journal.pmed.1001675.
38. World Health Organisation Tuberculosis Profile: South Africa 2013, [WWW Document]. URL, (accessed 08.15.13.). http://www.who.int/tb/data.
39. World Health Organisation Global Strategy and Targets for Tuberculosis Prevention, Care and Control after 2015 2015, (Geneva, Switzerland).
40. Wyszewianski L. Financially catastrophic and high-cost cases: definitions, distinctions, and their implications for policy formulation. Inquiry 1986, 23:382-394.
41. Xu K., Evans D.B., Kawabata K., Zeramdini R., Klavus J., Murray C.J.L. Household catastrophic health expenditure: a multicountry analysis. Lancet 2003, 362:111-117. 10.1016/S0140-6736(03)13861-5.